Clinical experience with the double-plate Ahmed glaucoma valve.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16458705.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the clinical efficacy and safety of the double-plate Ahmed Glaucoma Valve. Multicenter, retrospective observational case series. We reviewed 50 eyes in 50 patients treated with the double-plate Ahmed Glaucoma Valve with mean follow-up of 11.7+/-7.9 months. Average intraocular pressure was reduced from 36.0+/-12.4 mm Hg before surgery to 15.8+/-7.7 mm Hg at the most recent follow-up after surgery (P<.001). The number of glaucoma medications was decreased from 3.3+/-0.8 before surgery to 1.4+/-1.4 after surgery (P<.001). The percent of success was 76% of eyes at the latest follow-up. Choroidal effusion occurred in four eyes (8%) and did not require surgical treatment in any eye. Despite a poor prognosis group of patients in this study, the double-plate Ahmed Glaucoma Valve was effective in lowering intraocular pressure with a low incidence of complications associated with hypotony.
Medical subject headings
- Glaucoma Drainage Implants
- Glaucoma, Neovascular
- Glaucoma, Open-Angle
- Prosthesis Implantation